{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:30:37Z","timestamp":1790134237983,"version":"4.0.1"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.phrs.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T05:45:23Z","timestamp":1487742323000},"page":"77-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Cell therapy for heart disease after 15 years: Unmet expectations"],"prefix":"10.1016","volume":"127","author":[{"given":"Patrizia","family":"Nigro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cavallotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Catto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Carbucicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pompilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.02.015_bib0005","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics-2016 update: a report from the american heart association","volume":"133","author":"[1].Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0010","article-title":"Cardiovascular disease in europe: epidemiological update","volume":"2016","author":"Townsend","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0015","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/eurheartj\/ehl388","article-title":"Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the repair-ami trial","volume":"27","author":"Schachinger","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the boost randomized controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.02.015_bib0025","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The myoblast autologous grafting in ischemic cardiomyopathy (magic) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ccd.20406","article-title":"Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium","volume":"65","author":"Katritsis","year":"2005","journal-title":"Catheter. Cardiovasc. Interv. Off. J. Soc. Cardiac Angiogr. Interv."},{"key":"10.1016\/j.phrs.2017.02.015_bib0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","article-title":"Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction","volume":"94","author":"Chen","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0045","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0050","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2017.02.015_bib0055","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","article-title":"Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts","volume":"50","author":"Caspi","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0060","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0065","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1161\/CIRCULATIONAHA.111.084343","article-title":"Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model","volume":"126","author":"Kawamura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phrs.2017.02.015_bib0075","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0080","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2006.07.044","volume":"48","author":"Engelmann","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0085","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/ATVBAHA.109.197434","article-title":"Microrna-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells","volume":"30","author":"Sluijter","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","article-title":"Exosomes and cardiac repair after myocardial infarction","volume":"114","author":"Sahoo","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/heartjnl-2013-304955","article-title":"G-csf treatment for stemi: Final 3-year follow-up of the randomized placebo-controlled stem-ami trial","volume":"100","author":"Achilli","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2017.02.015_bib0100","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Schachinger","year":"2006","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0105","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/eurheartj\/ehn436","article-title":"Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction","volume":"29","author":"Huikuri","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0110","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2009.02.051","article-title":"The balance study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction","volume":"53","author":"Yousef","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00392-013-0595-9","volume":"102","author":"Wohrle","year":"2013","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0120","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/eurheartj\/ehp220","article-title":"Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with st-segment elevation myocardial infarction: 4 years follow-up","volume":"30","author":"Cao","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehp073","volume":"30","author":"Tendera","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0130","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1093\/eurheartj\/ehp374","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled boost trial","volume":"30","author":"Meyer","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0135","first-page":"70","article-title":"Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the mystar prospective, randomized study. Nature clinical practice","volume":"6","author":"Gyongyosi","year":"2009","journal-title":"Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0140","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/hrt.2008.155077","article-title":"Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study","volume":"95","author":"Krause","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2017.02.015_bib0145","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/eurheartj\/ehq449","volume":"32","author":"Hirsch","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ejechocard\/jeq116","volume":"12","author":"Beitnes","year":"2011","journal-title":"Euro. J. Echocardiogr."},{"key":"10.1016\/j.phrs.2017.02.015_bib0155","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the time randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.02.015_bib0160","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2\u20133 weeks following acute myocardial infarction on left ventricular function: the latetime randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.02.015_bib0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijcard.2015.02.084","article-title":"Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: the china-ami randomized controlled trial","volume":"184","author":"Hu","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0170","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehv493","article-title":"A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the regenerate-ami clinical trialdagger","volume":"37","author":"Choudry","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(04)15689-4","volume":"363","author":"Kang","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.02.015_bib0180","first-page":"I145","volume":"114","author":"Kang","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0185","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2015.03.563","article-title":"Comparison of different bone marrow-derived stem cell approaches in reperfused stemi A multicenter, prospective, randomized, open-labeled tecam trial","volume":"65","author":"San Roman","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0190","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ahj.2015.07.005","article-title":"Granulocyte-colony stimulating factor for large anterior st-elevation myocardial infarction: rationale and design of the prospective randomized phase iii stem-ami outcome trial","volume":"170","author":"Achilli","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0195","doi-asserted-by":"crossref","first-page":"385124","DOI":"10.1155\/2011\/385124","article-title":"One-year safety analysis of the compare-ami trial: comparison of intracoronary injection of cd133 bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction","volume":"2011","author":"Mansour","year":"2011","journal-title":"Bone Marrow Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0200","doi-asserted-by":"crossref","first-page":"I178","DOI":"10.1161\/CIRCULATIONAHA.104.522292","article-title":"Intracoronary injection of cd133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety","volume":"112","author":"Bartunek","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2010.09.025","article-title":"Cd34(+) cell infusion after st elevation myocardial infarction is associated with improved perfusion and is dose dependent","volume":"161","author":"Quyyumi","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0210","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1089\/scd.2014.0111","article-title":"The cd133+ cell as advanced medicinal product for myocardial and limb ischemia","volume":"23","author":"Bongiovanni","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.phrs.2017.02.015_bib0215","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.ijcard.2013.04.112","article-title":"A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction","volume":"168","author":"Gao","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0220","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","article-title":"First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with st-segment elevation myocardial infarction","volume":"59","author":"Houtgraaf","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0225","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction","volume":"54","author":"Hare","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (caduceus): A prospective, randomized phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.02.015_bib0235","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/eurheartj\/eht372","article-title":"Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of st-segment elevation myocardial infarction: a collaborative meta-analysis","volume":"35","author":"Delewi","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0240","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ijcard.2014.11.005","article-title":"Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials","volume":"177","author":"Liu","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0245","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.111.086074","article-title":"Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis","volume":"126","author":"Jeevanantham","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0250","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/ehn220","article-title":"Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review","volume":"29","author":"Martin-Rendon","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0255","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jacc.2007.07.041","article-title":"Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials","volume":"50","author":"Lipinski","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0260","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCINTERVENTIONS.113.001009","article-title":"Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials","volume":"7","author":"de Jong","year":"2014","journal-title":"Circulation. Cardiovasc. Interv."},{"key":"10.1016\/j.phrs.2017.02.015_bib0265","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.116.304346","article-title":"Meta-analysis of cell-based cardiac studies (accrue) in patients with acute myocardial infarction based on individual patient data","volume":"116","author":"Gyongyosi","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(03)12111-3","article-title":"Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation","volume":"361","author":"Tse","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.02.015_bib0275","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0735-1097(03)00328-0","article-title":"Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study","volume":"41","author":"Fuchs","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0280","first-page":"574","article-title":"Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia","volume":"47","author":"Beeres","year":"2006","journal-title":"J. Nuclear Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0285","doi-asserted-by":"crossref","first-page":"684 e611","DOI":"10.1016\/j.ahj.2006.07.018","article-title":"Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results","volume":"152","author":"Beeres","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0290","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/eurheartj\/ehm485","article-title":"Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (protect-cad trial)","volume":"28","author":"Tse","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0295","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2009.685","article-title":"Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial","volume":"301","author":"van Ramshorst","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.02.015_bib0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ahj.2012.08.008","article-title":"Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison","volume":"164","author":"Rodrigo","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0305","first-page":"8","article-title":"Repeated intramyocardial bone marrow cell injection in previously responding patients with refractory angina again improves myocardial perfusion, anginal complaints, and quality of life","author":"Mann","year":"2015","journal-title":"Circulation. Cardiovasc. Interv."},{"key":"10.1016\/j.phrs.2017.02.015_bib0310","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous cd34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0315","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000320217","article-title":"Intracoronary autologous cd34+ stem cell therapy for intractable angina","volume":"117","author":"Wang","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.phrs.2017.02.015_bib0320","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/CCM.0000000000001138","article-title":"Intracoronary transfusion of circulation-derived cd34+ cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention","volume":"43","author":"Lee","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0325","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous cd34+ stem cells for intractable angina: a phase i\/iia double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0330","doi-asserted-by":"crossref","DOI":"10.3727\/096368916X691484","article-title":"Autologous cd34(+) cell therapy for refractory angina: 2\u2009year outcomes from the act34-cmi study","author":"Henry","year":"2016","journal-title":"Cell Transplant."},{"key":"10.1016\/j.phrs.2017.02.015_bib0335","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ahj.2013.03.003","article-title":"A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous cd34+ cell administration in patients with refractory angina: design of the renew study","volume":"165","author":"Povsic","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0340","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The renew trial: efficacy and safety of intramyocardial autologous cd34(+) cell administration in patients with refractory angina","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.phrs.2017.02.015_bib0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-989351","article-title":"Direct minimally invasive intramyocardial injection of bone marrow-derived ac133+ stem cells in patients with refractory ischemia: preliminary results","volume":"56","author":"Pompilio","year":"2008","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.phrs.2017.02.015_bib0350","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1532\/HSF98.20061054","article-title":"Intramyocardial implantation of cd133+ stem cells improved cardiac function without bypass surgery","volume":"10","author":"Klein","year":"2007","journal-title":"Heart Surg. Forum"},{"key":"10.1016\/j.phrs.2017.02.015_bib0355","first-page":"506","article-title":"Safety and efficacy of bone marrow-derived autologous cd133+ stem cell therapy","volume":"3","author":"Adler","year":"2011","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.phrs.2017.02.015_bib0360","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/CIRCRESAHA.115.303463","article-title":"Selected cd133(+) progenitor cells to promote angiogenesis in patients with refractory angina: final results of the progenitor randomized trial","volume":"115","author":"Jimenez-Quevedo","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0365","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3727\/096368912X636830","article-title":"Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up","volume":"22","author":"Haack-Sorensen","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.phrs.2017.02.015_bib0370","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2013.10.079","article-title":"Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina?final 3-year follow-up","volume":"170","author":"Mathiasen","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0375","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.cjca.2012.12.003","article-title":"Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials","volume":"29","author":"Li","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0380","doi-asserted-by":"crossref","first-page":"e64669","DOI":"10.1371\/journal.pone.0064669","article-title":"Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: a systematic review and meta-analysis","volume":"8","author":"Fisher","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.02.015_bib0385","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.115.308056","article-title":"Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis","volume":"118","author":"Khan","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0390","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.athoracsur.2008.08.068","article-title":"Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery","volume":"86","author":"Zhao","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.phrs.2017.02.015_bib0395","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jtcvs.2006.08.077","article-title":"Intramyocardial delivery of cd133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies","volume":"133","author":"Stamm","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.phrs.2017.02.015_bib0400","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"Karantalis","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0405","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ijcard.2013.01.217","article-title":"A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction","volume":"168","author":"Lu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0410","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.healun.2015.01.989","article-title":"Intramyocardial bone marrow mononuclear cell transplantation in ischemic heart failure: long-term follow-up","volume":"34","author":"Lehtinen","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.phrs.2017.02.015_bib0415","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12265-016-9686-0","article-title":"Implantation of a novel allogeneic mesenchymal precursor cell type in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting: an open label phase iia trial","volume":"9","author":"Anastasiadis","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0420","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/eurheartj\/ehu007","article-title":"Autologous cd133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the cardio133 trial","volume":"35","author":"Nasseri","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0425","first-page":"663","article-title":"Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during cabg versus cabg alone. Nature clinical practice","volume":"5","author":"Ang","year":"2008","journal-title":"Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0430","doi-asserted-by":"crossref","first-page":"I101","DOI":"10.1161\/CIRCULATIONAHA.105.000505","article-title":"Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial","volume":"114","author":"Hendrikx","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0435","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1745-6215-13-99","article-title":"Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the perfect phase iii randomized multicenter trial: study protocol for a randomized controlled trial","volume":"13","author":"Donndorf","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.phrs.2017.02.015_bib0440","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.CIR.0000070596.30552.8B","article-title":"Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure","volume":"107","author":"Perin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0445","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ahj.2011.01.028","article-title":"A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (focus-hf)","volume":"161","author":"Perin","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0450","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the poseidon randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.02.015_bib0455","doi-asserted-by":"crossref","first-page":"79 e71","DOI":"10.1016\/j.ahj.2007.04.051","article-title":"Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the tabmmi study)","volume":"154","author":"de la Fuente","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0460","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/01.RES.0000264508.47717.6b","article-title":"Transcoronary transplantation of functionally competent bmcs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the topcare-chd registry","volume":"100","author":"Assmus","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0465","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejheart.2008.05.010","article-title":"Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the danish stem cell study\u2013congestive heart failure trial (dancell-chf)","volume":"10","author":"Diederichsen","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2017.02.015_bib0470","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/eurjhf\/hfq095","article-title":"The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heart failure: the star-heart study","volume":"12","author":"Strauer","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2017.02.015_bib0475","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Effect of shock wave-facilitated intracoronary cell therapy on lvef in patients with chronic heart failure: the cellwave randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.02.015_bib0480","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the focus-cctrn trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.02.015_bib0485","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (msc-hf trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0490","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the tac-hft randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2017.02.015_bib0495","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","article-title":"A phase ii dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure","volume":"117","author":"Perin","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0500","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the c-cure (cardiopoietic stem cell therapy in heart failure) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0505","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (scipio): Initial results of a randomized phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.02.015_bib0510","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCRESAHA.115.304554","article-title":"Safety and efficacy of ixmyelocel-t: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy","volume":"115","author":"Henry","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0515","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/S0140-6736(16)30137-4","article-title":"Ixmyelocel-t for patients with ischaemic heart failure: A prospective randomized double-blind trial","volume":"387","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.02.015_bib0520","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","article-title":"Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the miheart study)","volume":"36","author":"Martino","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0525","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5966\/sctm.2015-0070","article-title":"Revive trial: retrograde delivery of autologous bone marrow in patients with heart failure","volume":"4","author":"Patel","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0530","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.344","article-title":"Cell therapy for heart disease: trial sequential analyses of two cochrane reviews","volume":"100","author":"Fisher","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2017.02.015_bib0535","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","article-title":"Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials","volume":"117","author":"Afzal","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0540","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.167.10.989","article-title":"Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis","volume":"167","author":"Abdel-Latif","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0545","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/CIRCRESAHA.115.307184","article-title":"Bone marrow cell therapy for ischemic heart disease: the never ending story","volume":"117","author":"Pompilio","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0550","first-page":"232","article-title":"Cell therapy for cardiac repair\u2013lessons from clinical trials. Nature reviews","volume":"11","author":"Behfar","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.phrs.2017.02.015_bib0555","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3727\/096368914X678436","article-title":"Mesenchymal stem cell insights: prospects in cardiovascular therapy","volume":"23","author":"Chou","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.phrs.2017.02.015_bib0560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4252\/wjsc.v7.i2.352","article-title":"Second-generation stem cells for cardiac repair","volume":"7","author":"Nunez Garcia","year":"2015","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0565","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","article-title":"Isolation and expansion of adult cardiac stem cells from human and murine heart","volume":"95","author":"Messina","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0570","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2013.04.022","article-title":"Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modelling","volume":"62","author":"Iglesias-Garcia","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0575","doi-asserted-by":"crossref","first-page":"C1234","DOI":"10.1152\/ajpcell.00402.2009","article-title":"Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies","volume":"299","author":"Ng","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0580","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1083\/jcb.200612094","article-title":"A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency","volume":"177","author":"Deasy","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0585","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/jcb.24166","article-title":"Functional heterogeneity of mesenchymal stem cells: implications for cell therapy","volume":"113","author":"Phinney","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phrs.2017.02.015_bib0590","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8","article-title":"Donor variation in the growth properties and osteogenic potential of human marrow stromal cells","volume":"75","author":"Phinney","year":"1999","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phrs.2017.02.015_bib0595","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2007-12-128702","article-title":"The cd34-like protein podxl and alpha6-integrin (cd49f) identify early progenitor mscs with increased clonogenicity and migration to infarcted heart in mice","volume":"113","author":"Lee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2017.02.015_bib0600","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3324\/haematol.13740","article-title":"Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against cd56, cd271, and mesenchymal stem cell antigen-1","volume":"94","author":"Battula","year":"2009","journal-title":"Haematologica"},{"issue":"Pt 7","key":"10.1016\/j.phrs.2017.02.015_bib0605","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1242\/jcs.113.7.1161","article-title":"Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model","volume":"113","author":"Muraglia","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.phrs.2017.02.015_bib0610","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/stem.312","article-title":"In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment","volume":"28","author":"Russell","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.phrs.2017.02.015_bib0620","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/bit.23193","article-title":"Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency","volume":"108","author":"Russell","year":"2011","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.phrs.2017.02.015_bib0625","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bone.2009.10.002","article-title":"Characterisation of human bone marrow stromal cell heterogeneity for skeletal regeneration strategies using a two-stage colony assay and computational modelling","volume":"46","author":"Sengers","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2017.02.015_bib0630","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.175943","article-title":"Aging and disease as modifiers of efficacy of cell therapy","volume":"102","author":"Dimmeler","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0635","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.vph.2012.04.002","article-title":"Mesenchymal stem cell therapy for heart disease","volume":"57","author":"Gnecchi","year":"2012","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0640","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/156652412800619950","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications","volume":"12","author":"De Miguel","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0645","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/cphy.c140082","article-title":"Aging effects on cardiac progenitor cell physiology","volume":"5","author":"Rota","year":"2015","journal-title":"Compreh. Physiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0650","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nbt.1615","article-title":"High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity","volume":"28","author":"Narva","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0655","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/CIRCRESAHA.113.302302","article-title":"Rejuvenation of human cardiac progenitor cells with pim-1 kinase","volume":"113","author":"Mohsin","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0660","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/emmm.200900045","article-title":"Molecular aging and rejuvenation of human muscle stem cells","volume":"1","author":"Carlson","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0665","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nature03260","article-title":"Rejuvenation of aged progenitor cells by exposure to a young systemic environment","volume":"433","author":"Conboy","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2017.02.015_bib0670","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/CIRCRESAHA.113.301690","article-title":"Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia","volume":"113","author":"Madonna","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0675","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/CIRCULATIONAHA.109.849588","article-title":"Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells","volume":"120","author":"Itzhaki-Alfia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0680","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.trsl.2012.05.009","article-title":"Patient profile modulates cardiac c-kit(+) progenitor cell availability and amplification potential","volume":"160","author":"Gambini","year":"2012","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0685","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/01.CIR.0000043246.74879.CD","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (topcare-ami)","volume":"106","author":"Assmus","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0690","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0695","doi-asserted-by":"crossref","first-page":"II213","DOI":"10.1161\/01.CIR.0000138398.77550.62","article-title":"Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy","volume":"110","author":"Perin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0700","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.RES.0000144798.54040.ed","article-title":"Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction","volume":"95","author":"Fernandez-Aviles","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0705","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","article-title":"Autologous bone marrow-derived stem-cell transfer in patients with st-segment elevation myocardial infarction: Double-blind, randomized controlled trial","volume":"367","author":"Janssens","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.02.015_bib0710","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/eurheartj\/ehl509","article-title":"Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction","volume":"28","author":"Seeger","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0715","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jacc.2009.10.059","article-title":"Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy","volume":"55","author":"Assmus","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0720","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.stemcr.2015.01.001","article-title":"In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure","volume":"4","author":"Bortolotti","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2017.02.015_bib0725","doi-asserted-by":"crossref","first-page":"473159","DOI":"10.1155\/2015\/473159","article-title":"Full gmp-compliant validation of bone marrow-derived human cd133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy","volume":"2015","author":"Belotti","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.phrs.2017.02.015_bib0730","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nbt.1516","article-title":"Characterization of human embryonic stem cells with features of neoplastic progression","volume":"27","author":"Werbowetski-Ogilvie","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0735","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/stem.37","article-title":"Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine","volume":"27","author":"Knoepfler","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0740","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1158\/0008-5472.CAN-07-2665","article-title":"Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0745","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","article-title":"Spontaneous human adult stem cell transformation","volume":"65","author":"Rubio","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0750","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","article-title":"Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation","volume":"69","author":"Rosland","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0755","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/clo.2009.0006","article-title":"Chromosomal instability of murine adipose tissue-derived mesenchymal stem cells in long-term culture and development of cloned embryos","volume":"11","author":"Qin","year":"2009","journal-title":"Cloning Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0760","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","article-title":"Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation","volume":"115","author":"Tarte","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2017.02.015_bib0765","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0014-4827(03)00287-8","article-title":"Aging-related attenuation of egf receptor signaling is mediated in part by increased protein tyrosine phosphatase activity","volume":"289","author":"Tran","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0770","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M000008200","article-title":"Aging fibroblasts present reduced epidermal growth factor (egf) responsiveness due to preferential loss of egf receptors","volume":"275","author":"Shiraha","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.02.015_bib0775","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1038\/srep03372","article-title":"Hematopoietic stem and progenitor cells acquire distinct DNA-hypermethylation during in vitro culture","volume":"3","author":"Weidner","year":"2013","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2017.02.015_bib0780","first-page":"S23","article-title":"Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the repair-ami trial: nature clinical practice","volume":"3","author":"Schachinger","year":"2006","journal-title":"Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0785","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.stemcr.2014.05.003","article-title":"Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo","volume":"3","author":"Chinnadurai","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.phrs.2017.02.015_bib0790","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing","volume":"14","author":"Francois","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2017.02.015_bib0795","first-page":"139","article-title":"Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment","volume":"42","author":"Holubova","year":"2014","journal-title":"Biol. J. Int. Assoc. Biol. Standard."},{"key":"10.1016\/j.phrs.2017.02.015_bib0800","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1161\/CIRCRESAHA.114.305567","article-title":"Recent developments in cardiovascular stem cells","volume":"115","author":"Madonna","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0805","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.yjmcc.2008.03.009","article-title":"Systems approaches to preventing transplanted cell death in cardiac repair","volume":"45","author":"Robey","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0810","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2006-03-013433","article-title":"Clinical trials with adult stem\/progenitor cells for tissue repair: let's not overlook some essential precautions","volume":"109","author":"Prockop","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2017.02.015_bib0815","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1089\/scd.2007.0214","article-title":"Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including tgfbeta1","volume":"17","author":"Doyle","year":"2008","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.phrs.2017.02.015_bib0820","doi-asserted-by":"crossref","first-page":"e37373","DOI":"10.1371\/journal.pone.0037373","article-title":"Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes","volume":"7","author":"Clifford","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.02.015_bib0825","doi-asserted-by":"crossref","first-page":"I150","DOI":"10.1161\/CIRCULATIONAHA.104.526749","article-title":"Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials","volume":"112","author":"Hou","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0830","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/01.CIR.0000062649.63838.C9","article-title":"Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labelling","volume":"107","author":"Aicher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0835","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1634\/stemcells.2005-0201","article-title":"Myocardial homing of nonmobilized peripheral-blood cd34+ cells after intracoronary injection","volume":"24","author":"Blocklet","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0840","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000163546.27639.AA","article-title":"Monitoring of bone marrow cell homing into the infarcted human myocardium","volume":"111","author":"Hofmann","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0845","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2009.04.097","article-title":"Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery","volume":"54","author":"Terrovitis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0850","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCRESAHA.109.212589","article-title":"Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction","volume":"106","author":"Cheng","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0855","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2741\/4002","article-title":"Cardiac tissue engineering: current state and perspectives","volume":"17","author":"Chiu","year":"2012","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.phrs.2017.02.015_bib0860","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm1391","article-title":"Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction","volume":"12","author":"Miyahara","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0865","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0870","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1634\/stemcells.2006-0771","article-title":"Bcl-2 engineered mscs inhibited apoptosis and improved heart function","volume":"25","author":"Li","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0875","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1073\/pnas.0604144103","article-title":"Ex vivo pretreatment of bone marrow mononuclear cells with endothelial no synthase enhancer ave9488 enhances their functional activity for cell therapy","volume":"103","author":"Sasaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.02.015_bib0880","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1161\/01.CIR.0000142866.50300.EB","article-title":"Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor trf2 in endothelial progenitor cells","volume":"110","author":"Spyridopoulos","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0885","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jtcvs.2007.07.071","article-title":"Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis","volume":"135","author":"Hu","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.phrs.2017.02.015_bib0890","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.tp.0000172178.35488.31","article-title":"Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium","volume":"80","author":"Maurel","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0895","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1532-429X-16-7","article-title":"Tracking of stem cells in vivo for cardiovascular applications","volume":"16","author":"Azene","year":"2014","journal-title":"J. Cardiovasc. Magn. Resonan."},{"key":"10.1016\/j.phrs.2017.02.015_bib0900","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.CIR.0000070931.62772.4E","article-title":"In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction","volume":"107","author":"Kraitchman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib0905","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1634\/stemcells.22-4-448","article-title":"Human embryonic stem cells possess immune-privileged properties","volume":"22","author":"Li","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0910","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1634\/stemcells.2005-0188","article-title":"Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells","volume":"24","author":"Drukker","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0915","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/17460751.3.4.531","article-title":"Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms","volume":"3","author":"Nasef","year":"2008","journal-title":"Regen. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib0920","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib0925","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1073\/pnas.0805802105","article-title":"Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts","volume":"105","author":"Swijnenburg","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.02.015_bib0930","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nbt0708-739","article-title":"Hla-haplotype banking and ips cells","volume":"26","author":"Nakatsuji","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0935","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12026-008-8088-z","article-title":"Suppression of hla expression by lentivirus-mediated gene transfer of sirna cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantation","volume":"44","author":"Hacke","year":"2009","journal-title":"Immunol. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0940","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nbt.2960","article-title":"Overcoming immunological barriers in regenerative medicine","volume":"32","author":"Zakrzewski","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0945","doi-asserted-by":"crossref","first-page":"1031794","DOI":"10.1155\/2016\/1031794","article-title":"Impact of timing following acute myocardial infarction on efficacy and safety of bone marrow stem cells therapy: a network meta-analysis","volume":"2016","author":"Liu","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.phrs.2017.02.015_bib0950","doi-asserted-by":"crossref","first-page":"212 e211","DOI":"10.1016\/j.ahj.2006.10.027","volume":"153","author":"Nyolczas","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0955","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1160\/TH09-08-0520","article-title":"Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. Noga-guided subanalysis of the mystar prospective randomized study","volume":"103","author":"Charwat","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.02.015_bib0960","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCRESAHA.116.308937","article-title":"Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy","volume":"119","author":"Tokita","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0965","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurjhf\/hfp062","article-title":"Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction","volume":"11","author":"Yao","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2017.02.015_bib0970","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/hrt.2008.149476","article-title":"Cell therapy for ischaemic heart disease","volume":"94","author":"Beeres","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2017.02.015_bib0975","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/eurheartj\/ehi159","article-title":"Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: The poznan trial","volume":"26","author":"Siminiak","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib0980","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0735-1097(03)00397-8","article-title":"Percutaneous transvenous cellular cardiomyoplasty: a novel nonsurgical approach for myocardial cell transplantation","volume":"41","author":"Thompson","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib0985","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1148\/radiol.14131424","article-title":"Fused x-ray and mr imaging guidance of intrapericardial delivery of microencapsulated human mesenchymal stem cells in immunocompetent swine","volume":"272","author":"Fu","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.phrs.2017.02.015_bib0990","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12265-012-9378-3","article-title":"Cell delivery routes for stem cell therapy to the heart: current and future approaches","volume":"5","author":"Campbell","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib0995","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12265-008-9080-7","article-title":"Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the noga xp cardiac navigation system","volume":"2","author":"Psaltis","year":"2009","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib1000","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4244\/EIJV8I6A113","article-title":"Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute st-elevation myocardial infarction: alster-stem cell trial","volume":"8","author":"Heeger","year":"2012","journal-title":"EuroInterven. J. EuroPCR"},{"key":"10.1016\/j.phrs.2017.02.015_bib1005","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","article-title":"A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction","volume":"27","author":"Freyman","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2017.02.015_bib1010","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1634\/stemcells.2005-0589","article-title":"Intracoronary infusion of cd133+ and cd133-cd34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution","volume":"24","author":"Goussetis","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2017.02.015_bib1015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/17460751.4.1.119","article-title":"Autologous bone marrow-derived stem cells for ischemic heart failure: regenerate-ihd trial","volume":"4","author":"Yeo","year":"2009","journal-title":"Regen. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib1020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/rme.14.3","article-title":"Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the regenerate-ihd pilot study","volume":"9","author":"Mozid","year":"2014","journal-title":"Regen. Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib1025","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCRESAHA.111.242909","article-title":"Imaging Guiding the clinical translation of cardiac stem cell therapy","volume":"109","author":"Nguyen","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib1030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib1035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.CIR.0000083233.86078.3E","article-title":"Clinical use of cardiovascular magnetic resonance","volume":"108","author":"Pohost","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib1040","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s00259-004-1490-4","article-title":"Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with fdg-pet and thallium spect","volume":"31","author":"Dobert","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.phrs.2017.02.015_bib1045","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.2967\/jnumed.110.078469","article-title":"The role of pet with 13n-ammonia and 18f-fdg in the assessment of myocardial perfusion and metabolism in patients with recent ami and intracoronary stem cell injection Journal of nuclear medicine: official publication","volume":"51","author":"Castellani","year":"2010","journal-title":"Soc. Nuclear Med."},{"key":"10.1016\/j.phrs.2017.02.015_bib1050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCIMAGING.109.854893","article-title":"Noninvasive assessment of myocardial perfusion","volume":"2","author":"Salerno","year":"2009","journal-title":"Circulation. Cardiovasc. Imaging"},{"key":"10.1016\/j.phrs.2017.02.015_bib1055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.echo.2007.01.010","article-title":"3d echocardiography: a review of the current status and future directions","volume":"20","author":"Hung","year":"2007","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.phrs.2017.02.015_bib1060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/157340309788166642","article-title":"Strain and strain rate imaging by echocardiography \u2212 basic concepts and clinical applicability","volume":"5","author":"Dandel","year":"2009","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.phrs.2017.02.015_bib1065","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.echo.2007.08.002","article-title":"Myocardial radial strain in early diastole is useful for assessing left ventricular early diastolic function: comparison with invasive parameters","volume":"21","author":"Wakami","year":"2008","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.phrs.2017.02.015_bib1070","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1161\/CIRCULATIONAHA.106.647172","article-title":"Role of tissue doppler and strain echocardiography in current clinical practice","volume":"116","author":"Abraham","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib1075","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2007.01.078","article-title":"Tissue doppler imaging a new prognosticator for cardiovascular diseases","volume":"49","author":"Yu","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib1080","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled boost (bone marrow transfer to enhance st-elevation infarct regeneration) trial","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib1085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity: a critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib1090","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1016\/j.ijcard.2013.04.152","article-title":"Autologous bone marrow-derived stem cell therapy in heart disease: discrepancies and contradictions","volume":"168","author":"Francis","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib1095","doi-asserted-by":"crossref","first-page":"g2688","DOI":"10.1136\/bmj.g2688","article-title":"Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (damascene): Weighted regression and meta-analysis","volume":"348","author":"Nowbar","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2017.02.015_bib1100","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2014.06.1175","article-title":"Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement","volume":"64","author":"Rosen","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib1105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.112.131110","article-title":"Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction","volume":"127","author":"Williams","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib1110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCRESAHA.109.208991","article-title":"Assessment and optimization of cell engraftment after transplantation into the heart","volume":"106","author":"Terrovitis","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib1115","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2006.06.005","article-title":"Biomaterials for the treatment of myocardial infarction","volume":"48","author":"Christman","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2017.02.015_bib1120","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/CIRCULATIONAHA.106.628623","article-title":"Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia","volume":"114","author":"Aicher","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2017.02.015_bib1125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s12975-012-0251-0","article-title":"Preconditioning strategy in stem cell transplantation therapy","volume":"4","author":"Yu","year":"2013","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.phrs.2017.02.015_bib1130","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1586\/14779072.2013.814830","article-title":"Cell and gene therapy for severe heart failure patients: the time and place for pim-1 kinase","volume":"11","author":"Siddiqi","year":"2013","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2017.02.015_bib1135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biomaterials.2015.05.005","article-title":"Epicardial application of cardiac progenitor cells in a 3d-printed gelatin\/hyaluronic acid patch preserves cardiac function after myocardial infarction","volume":"61","author":"Gaetani","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2017.02.015_bib1140","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1160\/TH14-05-0480","article-title":"Vascularisation for cardiac tissue engineering: the extracellular matrix","volume":"113","author":"Patra","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.02.015_bib1145","first-page":"2208","article-title":"Cardiopulse articles","volume":"37","year":"2016","journal-title":"Eur. Heart J."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816310003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816310003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T15:04:21Z","timestamp":1658675061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816310003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":229,"alternative-id":["S1043661816310003"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.02.015","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell therapy for heart disease after 15 years: Unmet expectations","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}